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Curcuminoids are produced by plants of the order Zingiberales, and often used in 
food additives and also in traditional Asian medicines due to their anti-tumour 
properties. Therefore, they constitute very attractive targets to metabolic engineering 
[1]. The aim of this work is to engineer a biosynthesis pathway for the production of 
curcumin in Escherichia coli by combining a systems biology approach with synthetic 
biology. 
 
Synthetic biology provides an answer to the challenge of expanding the biological 
production capabilities of microorganisms through the incorporation in the host of 
engineered biosynthetic pathways for compounds of interest. 
 
The design of biosynthetic pathways for both natural and unnatural compounds can be 
performed by assembling partial pathways recruited from different species [2,3], by 
engineering existing pathways and by the use of engineered enzymes exploring the 
natural diversity of enzyme-catalyzed reactions across several species. Key to this is 
the specification of gene sequences encoding enzymes that catalyze each reaction in 
the pathway and whose DNA sequences can be incorporated into devices that lead to 
functional expression of the molecules of interest [4,5].  
 
To identify all the possible metabolic routes that allow the production of curcumin 
from metabolites that exist in native E. coli we used relevant databases like Kegg and 
MetaCyc. Then to each one of the identified reactions it was identified the species 
with the corresponding enzymes/genes. Afterwards, all the possible routes were 
incorporated in genome-scale stoichiometric models [6] coupled with the dynamic 
model to understand the likely limitations regarding the availability of the possible 
precursors. The inclusion of these possible set of pathways in a in silico model help to 
predict the cell behavior after their incorporation, such as product yield and cell 
growth, stoichiometric constraints and also to assess the potential of the successful 
implementation of a designed pathway by using other bioinformatics tools.  
 
Further, the optimization of these synthetic biology modified strains using in silico 
metabolic models leads to the high-level production of specific metabolites in an 
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